Identification of Withaferin a as a Potential Candidate for Anti-Cancer Therapy in Non-Small Cell Lung Cancer

Cancers - Switzerland
doi 10.3390/cancers11071003
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

MDPI AG

Related search

Newly Developed Anti-Angiogenic Therapy in Non-Small Cell Lung Cancer

Oncotarget
Oncology
2017English

Identification of Circulating Long Non-Coding RNA GAS5 as a Potential Biomarker for Non-Small Cell Lung Cancer Diagnosis

International Journal of Oncology
Cancer ResearchOncology
2017English

Plasma microRNAs as Potential Biomarkers for Non-Small-Cell Lung Cancer

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2010English

A Decade of Targeted Therapy for Non-Small Cell Lung Cancer

2017English

New Strategies in Lung Cancer: Epigenetic Therapy for Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Hsa_circ_0033155: A Potential Novel Biomarker for Non‑small Cell Lung Cancer

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

Hmgb1: A Potential Therapeutic Target for Non-Small Cell Lung Cancer

Lettters in Health & Biological Sciences
2016English

Synergistic Combinations of Paclitaxel and Withaferin a Against Human Non-Small Cell Lung Cancer Cells

Oncotarget
Oncology
2020English

Clarification Needed Regarding Anti-Topoisomerase I as a Biomarker for Non-Small Cell Lung Cancer

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy